1. Home
  2. TLSI vs CBNA Comparison

TLSI vs CBNA Comparison

Compare TLSI & CBNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • CBNA
  • Stock Information
  • Founded
  • TLSI 2010
  • CBNA 2006
  • Country
  • TLSI United States
  • CBNA United States
  • Employees
  • TLSI N/A
  • CBNA N/A
  • Industry
  • TLSI Medical Specialities
  • CBNA
  • Sector
  • TLSI Health Care
  • CBNA
  • Exchange
  • TLSI Nasdaq
  • CBNA NYSE
  • Market Cap
  • TLSI 160.4M
  • CBNA 159.8M
  • IPO Year
  • TLSI N/A
  • CBNA 2024
  • Fundamental
  • Price
  • TLSI $5.74
  • CBNA $24.48
  • Analyst Decision
  • TLSI Strong Buy
  • CBNA Buy
  • Analyst Count
  • TLSI 6
  • CBNA 3
  • Target Price
  • TLSI $11.75
  • CBNA $29.67
  • AVG Volume (30 Days)
  • TLSI 57.4K
  • CBNA 14.0K
  • Earning Date
  • TLSI 05-14-2025
  • CBNA 05-15-2025
  • Dividend Yield
  • TLSI N/A
  • CBNA N/A
  • EPS Growth
  • TLSI N/A
  • CBNA 115.79
  • EPS
  • TLSI N/A
  • CBNA 4.17
  • Revenue
  • TLSI $29,431,000.00
  • CBNA $53,113,000.00
  • Revenue This Year
  • TLSI $55.08
  • CBNA N/A
  • Revenue Next Year
  • TLSI $50.75
  • CBNA $22.92
  • P/E Ratio
  • TLSI N/A
  • CBNA $5.87
  • Revenue Growth
  • TLSI 58.99
  • CBNA 74.81
  • 52 Week Low
  • TLSI $3.50
  • CBNA $20.01
  • 52 Week High
  • TLSI $10.24
  • CBNA $27.56
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 59.91
  • CBNA N/A
  • Support Level
  • TLSI $5.23
  • CBNA N/A
  • Resistance Level
  • TLSI $5.66
  • CBNA N/A
  • Average True Range (ATR)
  • TLSI 0.34
  • CBNA 0.00
  • MACD
  • TLSI 0.03
  • CBNA 0.00
  • Stochastic Oscillator
  • TLSI 92.94
  • CBNA 0.00

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About CBNA CHAIN BRIDGE BANCORP INC

Chain Bridge Bancorp Inc is engaged in banking industry. It offers commercial and personal banking services, including deposits, treasury management, payments, loans, commercial lending, residential mortgage financing, consumer loans, trusts and estate administration, wealth management, and asset custody.

Share on Social Networks: